ArtificaX is a deep‑tech company that commercializes frontier research through two core platforms: AXAgents, an AI‑agents application designed for real‑world workflows, and RapidDrug, an AI‑powered drug‑discovery system that performs billion‑ligand‑scale in‑silico screening up to 1,000× faster and at a fraction of traditional costs. By combining rigorous R&D with productization, ArtificaX enables faster, more cost‑effective innovation in both AI and pharmaceutical research.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical research and development often rely on costly, time‑consuming experimental screening of chemical compounds, limiting the speed at which viable drug candidates can be identified. Additionally, many organizations lack accessible AI tools that can automate routine workplace tasks, reducing operational efficiency.
Solution
ArtificaX offers two AI‑driven platforms to address these challenges. RapidDrug provides an end‑to‑end, in‑silico drug discovery workflow capable of screening billions of ligands, delivering results up to 1,000 × faster and at a fraction of traditional laboratory costs. AXAgents delivers autonomous AI agents that can be deployed for practical workplace tasks, enabling organizations to automate repetitive processes and improve productivity. Both platforms translate frontier AI research into commercial products, allowing users to leverage high‑performance machine‑learning models without building their own infrastructure.
Target Audience
Primary customers are pharmaceutical and biotech companies seeking accelerated early‑stage drug discovery, as well as enterprises looking to automate knowledge‑work tasks with AI agents.
Features
- Billion‑ligand‑scale virtual screening engine powered by deep learning models for rapid hit identification
- Fully automated workflow covering target selection, docking, scoring, and candidate ranking
- Cloud‑native architecture that scales compute resources on demand, reducing hardware investment
- AXAgents suite of customizable autonomous agents for task automation, data extraction, and workflow orchestration
- Low‑code integration APIs that allow rapid deployment of AI agents within existing enterprise systems
- Secure data handling and encryption to protect proprietary compound libraries and business information